← All stocks

Adicet Bio, Inc.

ACET No buying or selling
CIK 0001720580 #4407 in the set updated 18 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

11 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
10% owner
932,624
$6.08M
−2.8%
Klickstein Lloyd
Chief Medical Officer
108,566
$707.85K
+5.7%
DUBIN STEVE
Director
22,700
$148.00K
+35.1%
Chodakewitz Jeffrey
Director
17,700
$115.40K
+50.0%
Sinclair Andrew
Director
17,700
$115.40K
+50.0%
Peng Katie
Director
11,800
$76.94K
+100.0%
Schor Chen
President & CEO
6,820
$44.47K
−81.4%
Harvey Brian Nicholas
Chief Financial Officer
5,145
$33.55K
−64.4%
Healey Don
Chief Technology Officer
3,452
$22.51K
−72.5%
Aftab Blake
Chief Scientific Officer
2,981
$19.44K
−69.5%
ORBIMED ADVISORS LLC entity
10% owner
0
$0.00

No percentages here. This company's share count has moved by a factor of 16.4 over the window, from 9,361,490 to 153,255,581 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 30 Jan 2018